Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, ...

Sodium bicarbonate is one medication used to treat kidney disease. ... It can also be given by intravenous injection or infusion. What is the goal of treating kidney disease with sodium bicarbonate?

Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium ...

The 3 recalled lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1000mL; NDC# 70324-326-01, were distributed to hospitals nationwide between May and June 2021 and include the following: ...

Sodium Bicarbonate Injection supply is historically unstable, creating a challenging environment for hospitals and the patients they serve," said Peter Karas, ...

SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC ...

Sodium bicarbonate treatment may not exactly protect patients from contrast-induced nephropathy (CIN), the kidney injury resulting from an injection administered in order improve x-ray image.

Milled sodium bicarbonate has been known to be more reactive than trona in mitigating SO 2, ... A five-hour sodium bicarbonate injection test was conducted on Unit 2 in late November 2007.